About Comms

This author has not yet filled in any details.
So far Comms has created 398 blog entries.

INFANT Collaborators from Tanzania visit Cork

By |2024-12-09T10:13:05+00:00December 9th, 2024|

From 25th – 29th November, we welcomed long-time collaborators from Kilimanjaro Christian Medical Center (KCMC), Kilimanjaro Christian Medical University College (KCMUCo) and Kilimanjaro Clinical Research Institute (KCRI) to INFANT, UCC.

We hosted our esteemed collaborators Professor Blandina Mmbaga and Professor Levina Msuya, from KCMC, KCRI and KCMUCo in Tanzania, for an enriching visit to Cork. The week was filled with engaging discussions, knowledge sharing, and planning for future collaborations.

Key highlights of the visit:

Prof Mmbaga and Prof Msuya met with team members across INFANT, toured facilities in CUH and CUMH including the NICU, gave two insightful talks and discussed future collaboration opportunities in maternal and child health and nutrition, and future plans for scaling up the Kilimanjaro Ultra Birth Registry, a joint INFANT/KCRI joint project, in Tanzania and the East Africa region

The insightful lunchtime talks included “Paediatrics Services – Challenges & Opportunities at KCMC” and “Ongoing research in paediatric & neonatal care at KCRI“.

The visit also included plans to scale up ongoing projects, promote clinical collaboration and clinical skills exchange, secure future research funding and continue to drive impactful global health research.

Professor Mmbaga and Professor Msuya bring invaluable expertise, bridging clinical and research knowledge to further strengthen the partnership. We look forward to building on our partnership and driving impactful change in maternal and child health.

Thank you to the ESTHER Ireland partnership strenghtening grant for supporting the visit: https://www.esther.ie/

INFANT Director Awarded Association Conference Award

By |2024-12-09T09:49:09+00:00December 9th, 2024|

On Thursday, 28th November, INFANT team members attended the Cork Convention Bureau Conference Ambassador Awards 2024 , a fantastic event celebrating individuals who have made a significant impact by bringing international conferences to Cork. These ambassadors play a vital role in driving business tourism and enhancing Cork’s reputation as a leading European destination for big conventions.

During the event, there were four overall category winners 🎖️ recognising outstanding individuals for their contributions in hosting international conferences in Cork and the substantial economic value they have.

Professor Geraldine Boylan, INFANT, UCC Director won the Association Conference Award for her outstanding work in bringing the 15th Newborn Brain Conference  to Cork earlier this year, an event that welcomed over 420 delegates!

Collectively, colleagues at University College Cork efforts brought many conferences to Cork which had an impressive economic value of €8 million in 2023/24.

New insights to improving outcomes after newborn brain injury, research published in the Lancet

By |2024-12-03T11:20:25+00:00December 3rd, 2024|

On International Day of Persons with Disabilities, we caught up with INFANT collaborator, Professor Cally Tann and the Baby BRAiN research team to learn about their work to improve outcomes for children and families affected by newborn brain injury.

Newborn brain injury, caused by oxygen deprivation around the time of birth (birth asphyxia), is one of the leading causes of death and disability globally among children less than five years of age.  Developmental disabilities like cerebral palsy, as a result of birth complications, can affect a child’s movement, learning, feeding, vision and hearing, with far reaching implications on a child’s health, well-being and quality of life. Superstitious beliefs around developmental disabilities often mean that families experience discrimination and exclusion from their communities, with important psychological, social and financial impacts for caregivers and families.

The majority of newborn brain injury (95%) occurs in low- and middle-income countries (LMICs), with half occurring in sub-Saharan Africa. Despite this, relatively little is known about how we might effectively treat affected newborns in low-income countries, particularly in settings without access to newborn intensive care facilities.

About the Baby BRAiN study

The Baby BRAiN study aimed to improve our understanding of newborn brain injury in Uganda and examined the impacts of events around the time of birth on both the baby’s brain and the child’s longer-term outcomes.

Newborn seizures (fitting) can be common amongst affected babies, and studies from high-income countries have shown that severe or prolonged fitting can substantially increase the risk of death and longer-term disabilities. Video electroencephalography (EEG), which measures the electrical activity of the brain, can help monitor the severity of brain injury and seizures. However, their use in LMICs remain limited and as a result, seizures occurring after brain injury are at risk of being undetected or misdiagnosed.

The study, conducted at Kawempe National Referral Hospital, Kampala, Uganda, is the first to use the gold-standard video EEG monitoring, to examine brain function amongst a population of African newborns without access to intensive care.

The Baby BRAiN team recently published two papers which provide unique insights into the impact of birth complications on the newborn brain. The research, conducted in partnership with the neonatal neurophysiology team at the INFANT Research Centre at University College Cork (UCC), showed that newborn seizures were common, but difficult to detect and effectively treat without specific monitoring.  As a result, fitting was often prolonged or continuous, which can substantially increase the risk of death and disability in settings without access to newborn intensive care. Those with the most severe brain dysfunction were found to be at the greatest risk of death or disability in early childhood.

Carol Nanyunja, the Research Coordinator for the Baby BRAiN study at MRC/UVRI and LSHTM Uganda Research Unit, said: “The Baby BRAiN study in Uganda provides new data that will help us better understand and treat newborn brain injury in LMICs”

What is next?

These new insights from the Baby BRAiN study have provided evidence to guide the clinical assessment and treatment of newborns with brain injury. Further data on the longer-term impacts of brain dysfunction and seizures from LMICs is required to help us understand the long-term outcomes for affected children and their families.

Cally Tann, Professor of Neonatal Medicine and International Child Health at LSHTM, said:

“This study shows the impact of birth complications on the newborn brain and highlights the need to enhance efforts to find new and innovative ways to prevent injury and protect newborns’ developing brains.”

Geraldine Boylan, Professor of Neonatal Physiology and Director of the INFANT Research Centre at UCC, said:

“Novel innovations to monitor brain dysfunction in diverse settings could substantially improve our understanding of newborn brain injury and support effective clinical management of seizures to improve outcomes for affected children.”

The research was funded by the Gates Foundation, as part of a ‘neonatal neuroprotection consortium’, of which Professor Tann is part. The consortium aims to find novel solutions to neuroprotection for babies born in low-income countries. Clinical trials to explore new prevention and intervention strategies for newborn brain injury are underway, with several agents showing promise in preclinical studies.

Add links to publications.

  • Mathieson SR, Nanyunja C, Sadoo S, Nakalembe S, Duckworth E, Muryasingura S, et al. EEG background activity, seizure burden and early childhood outcomes in neonatal encephalopathy in Uganda: a prospective feasibility cohort study. eClinicalMedicine. 2024;78. doi: 10.1016/j.eclinm.2024.102937

https://doi.org/10.1016/j.eclinm.2024.102937

  • Proietti J, Nanyunja C, Mathieson SR, Duckworth E, Sadoo S, Mambule I, Nakimuli A, Tann CJ, Boylan GB. Retrospective characterization of seizure semiology and treatment using continuous video-EEG monitoring in neonatal encephalopathy in Uganda. Epileptic Disord. 2024 Nov 18. doi: 10.1002/epd2.20299. Epub ahead of print. PMID: 39556089.

https://onlinelibrary.wiley.com/doi/epdf/10.1002/epd2.20299

 

 

INFANT, UCC Spinout Company, CergenX Wins Irish Times Innovation Award in Life Sciences & Healthcare

By |2026-08-31T20:03:31+01:00November 13th, 2024|

CergenX has been awarded the prestigious Irish Times Innovation Award in the Life Sciences & Healthcare category, sponsored by Research Ireland.

This award celebrates their innovation in neonatal brain health, particularly with their new, easy-to-use brain-monitoring technology called Wave. The Wave device helps identify newborns in need of extra support or treatment, with the aim of reducing the impact of brain injury on their lives.

Most of the time, when a baby is born everything goes smoothly. But for some babies, complications can lead to brain injury, hard-to-detect seizures and even problems in later life so early intervention is critical.

Wave aims to solve this by using a quick, easy EEG (electroencephalogram) monitoring system that requires only 10 minutes. The data wings its way to the cloud, where it is analysed by CergenX’s AI, and within seconds the results are back, clearly highlighting whether the results showed any abnormal findings, so medical teams can make important decisions quickly.

The Wave technology emerged from research carried out at the INFANT Research Centre at University College Cork, underlining Ireland’s robust contributions to the medtech sector and CergenX CEO Jason Mowles wants to see it benefit babies around the world.

The Irish Times Innovation Awards, now in their 15th year, are one of Ireland’s most celebrated annual events, bringing recognition to pioneering companies and entrepreneurs. This year, the awards continue to honour innovations across diverse fields, including food and agribusiness, manufacturing, IT, sustainability, and emerging technologies such as AI and fintech.

Reference: Innovation Awards finalist: CergenX technology offers fast brain-injury assessment in babies – The Irish Times

Image: Dr Siobhan Roche, Director, Science for the Economy at Research Ireland, Sean Griffin, CTO, CergenX and Jason Mowles, CEO, CergenX

Dr Cathal O’Connor Awarded Dermatology Research Award

By |2024-11-05T13:26:49+00:00November 5th, 2024|

Dr Cathal O’Connor won the Dermatology Research Award at the all-island Royal Academy of Medicine in Ireland Research Awards, held at the Royal College of Surgeons in Ireland.

Cathal’s publication ‘Early emollient bathing is associated with subsequent atopic dermatitis in an unselected birth cohort study’ was published in the leading journal EAACI PAI Journal – Pediatric Allergy and Immunology and was voted the bestresearch published by an Irish author in dermatology in 2023.

This paper examined early bathing exposures in babies and their eczema outcomes. It showed that emollient bathing at 2 months of age might increase the risk of subsequent eczema development. The paper reviewed data from the BASELINE birth cohort study, a landmark study which was performed in Cork.

Cathal undertook his PhD at the INFANT Research Centre as part of the prestigious Irish Clinical Academic Training (ICAT) Programme and is currently completing a postdoctoral fellowship at Great Ormond Street Hospital and the Crick Institute in London.

📰 Read the paper here: Early emollient bathing is associated with subsequent atopic dermatitis in an unselected birth cohort study – O’Connor – 2023 – Pediatric Allergy and Immunology – Wiley Online Library

Dr Aoife Gallagher Awarded The Sir Henry Marsh Medal

By |2024-11-05T13:12:36+00:00October 11th, 2024|

INFANT Clinical Research Fellow Dr Aoife Gallagher won the Sir Henry Marsh medal.

The Sir Henry Marsh medal award is an annual award given by the Faculty of Paediatrics to the lead author of the best paper by a Paediatric Trainee on the topic of child health or the delivery of child healthcare in Ireland published in the preceding calendar year. Aoife was presented with the medal at Faculty of Paediatrics Autumn conference on 11th October.

Her article “Dietary Advancement Therapy using milk and egg ladders among children with a history of anaphylaxis” was recently published in The Journal of Allergy and Clinical Immunology: In Practice and also selected as a “Practice Changer” – one of the for the four most practical and clinically impactful Original Articles published in JACI: In Practice each month.

Read more about the publication here: Dietary Advancement Therapy Using Milk and Egg Ladders Among Children With a History of Anaphylaxis – ScienceDirect

Interview: Cerebral Palsy Foundation Chair in Early Brain Injury and Cerebral Palsy: Professor Deirdre Murray, One Year On

By |2024-10-07T12:16:52+01:00October 7th, 2024|

On World Cerebral Palsy Day, October 6th, 2023, University College Cork (UCC) proudly announced the appointment of Professor Deirdre Murray as the Cerebral Palsy Foundation Chair in Early Brain Injury and Cerebral Palsy, marking the start of a transformative programme aimed at revolutionising cerebral palsy care in Ireland.

A UCC alumna, Professor Murray graduated in 1995 before completing paediatric training in Paediatric Intensive Care Medicine at Bristol Royal Hospital for Sick Children. Her journey continued as a Paediatric Intensive Care Fellow at the Royal Children’s Hospital in Melbourne. In 2012, she was awarded the prestigious Health Research Board Clinician Scientist Award for the BiHiVE study, which focuses on discovering biomarkers for neonatal brain injury.

Fast forward to World Cerebral Palsy Day, October 6th, 2024: We sit down with Professor Murray to reflect on her first year as Chair and the progress made.

Can you tell us more about your role as Chair (and your other roles) and the key areas of research you’re currently focusing on?

I am a consultant paediatrician in Cork University Hospital and I am also the Professor of Paediatrics in University College Cork. This means that I have time for research and teaching. My research has always been focused on trying to find better ways to predict and detect early brain injury. One year ago I was lucky enough to be funded by the Cerebral Palsy Foundation(CPF) to take up the role of Chair in Early Brain Injury and Cerebral Palsy. This allows me to really focus on this area of research which is very exciting. I feel privileged to be allowed to work on the area that I am most passionate about as I believe that this will allow us to make major steps forward in the prediction, detection and treatment of Cerebral Palsy (CP).

Looking back on your first year, what are some of the key highlights, milestones, or breakthroughs that stand out?

Last summer myself and the team at the INFANT centre worked on a proposal to Science Foundation Ireland for a Strategic Partnership Programme of research in Cerebral Palsy. This was co-funded by the Cerebral Palsy Foundation. Soon after taking up the post in October last year we heard that the proposal was successful and that SFI had agreed to match the donation that we received from CPF to fund this very ambitious programme of research which we called the ELEVATE programme. Over the next 5 years the team at INFANT, and researchers in TCD and RCSI will work on improving our ability to predict, prevent, detect and treat early brain injury and cerebral palsy.

Another highlight was launching the programme in March 2024, in particular because as part of the launch we held a Townhall meeting here in Cork where we got to meet with many of the parents and families affected by CP. This always gives us motivation to keep going and work hard to try to solve problems for these families.

This research will have a profound impact on children and their families. Can you share how the work is already making a difference?

I am part of a team that is delivering an early detection pathway for high-risk infants. All high risk children born in the four largest maternity hospitals are now examined carefully before they go home from the Neonatal units, and again at 3 months, 9 months and 24 months of age. The aim is to dramatically reduce the age at which children are diagnosed with CP to less than 12 months and ideally 9 months. This will allow us to enroll these children in trials of very early focused interventions which we hope will improve long term mobility and outcome. We will be providing access to expert information and guidance and are currently developing educational materials for the families. We have a parent advisory group, built from all over Ireland with parents of children with CP who have kindly given up their time to help and have guided us every step of the way.

Last year I was invited to take part in a Global consortium called CP360. This alliance involves researchers and families from all over the world who are working together to improve care for people with CP. Within this consortium I am working as part of a group to develop a universal screener for cerebral palsy that can be scaled and used anywhere in the world. We hope that in the near future it will be possible for parents or caregivers to send short videos of their infants to a large and secure database which will anonymously and automatically identify those children at risk of CP to detect and diagnose the 1-2 per 1000 children who have CP as early as possible.

This will be a game-changer for early intervention.

What have been the biggest challenges you’ve faced in this role?

It has to be time. We are so impatient to make progress, but the care for people with CP in Ireland is currently so fragmented that it is hard to know where to start. Our focus is on research from 0-3 years, in particular on prediction and early detection. We need to get this sorted first, and then build on that by building expertise in early intervention. Families are crying out for interventions for older children, but we have to focus on the area where we have expertise and do this one step at a time. That is hard and I wish every day that I could do more.

You work with a multidisciplinary team and collaborate with partners globally. How do these partnerships strengthen progress in early brain injury and cerebral palsy research?

As part of the ELEVATE programme we will work with collaborators in Sweden, Italy, USA as well as our co-investigators in Dublin. We have long established collaborations with many researchers all over the world, all with the focus of improving the care of the newborn brain and preventing, detecting and treating early brain injury. This helps us to ensure that our research is cutting edge and that we are bringing the latest methods and ideas back to our centre to keep pushing things forward to improve care.

How important is the input from patients and families, and how have you integrated their perspectives into the research over the past year?

It is integral. We are very aware that parents are the ones that know the most important research questions. Our Parent Advisory Group give their time to review all of our documents, our protocols and plans to ensure that the aims make sense for families.

They have also helped to guide us on our parent educational materials. We asked them “What do you wish someone had told you when you first received the diagnosis of CP for your child?” “What way would you have liked the material delivered to you and by who?” “What topics, how detailed, etc?”. This information is vital for us as we need to get this right.

Looking ahead, what are your key priorities for the coming year and beyond as you continue in this role?

I am working with the CPF and my colleagues in Dublin, Dr Jennifer Ryan and Prof Denise McDonald to bring attention to the needs of children and adults with CP in Ireland; pushing to try to develop clinical care pathways for the time beyond the first 3 years of life. The injury that causes CP occurs once but the ongoing difficulties faced by these children progress as they get older, and their needs often become greater.

Unfortunately, at the moment in Ireland the support needed for many of these steps is missing or fragmented and care depends on where you live and what the local team can offer. Access to high quality care should be equitable for all children no matter where they live. A national clinical programme of care for CP would help us move towards that goal.

In the INFANT centre we are building the ELEVATE team and hope to start recruiting infants to the study within the next few weeks. We are working with our Swedish collaborators to access large amounts of pregnancy and birth data from Sweden to develop automated risk algorithms using this data to identify babies most at risk of CP at the time of birth. We are looking at what proteins might be measurable in blood tests soon after birth to detect brain injury. We will also be looking at brain waves measured using EEG at 3-4 months of age to see what clues they can give us about brain insults and outcome.

Next we will be looking at better ways of assessing young children with brain injury to predict co-existing learning difficulties.  Standard ways of assessing children with brain injury are very difficult it they have visual problems, or movement difficulties. We are developing ways to work around this to give us a true picture of the child’s learning potential.

I am impatient to get started and looking forward to what the next four years will bring.

Go to Top